Lateral Flow Assay Components Market worth $486.2 million by 2030
The report "Lateral Flow Assay Components Market by Type (Membrane, Pad), Application (Clinical Testing (Infectious, Cardiac Marker Test, Fertility, Pregnancy, Cholesterol Testing), Veterinary, Food Safety), Technique, End User & Region - Global Forecast to 2030 ", is projected to reach USD 486.2 million by 2030 from USD 392.4 million in 2025, at a CAGR of 4.4% during the forecast period.
Browse 335 market data Tables and 42 Figures spread through 285 Pages and in-depth TOC on "Lateral Flow Assay Components Market by Type (Membrane, Pad), Application (Clinical Testing (Infectious, Cardiac Marker Test, Fertility, Pregnancy, Cholesterol Testing), Veterinary, Food Safety), Technique, End User & Region - Global Forecast to 2030 "
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/lateral-flow-assay-components-market-45058941.html
The market for LFA components is driven by the high prevalence of infectious diseases, the growing geriatric population, and the increased use of home-based and point-of-care (POC) diagnostic tests. These factors boost demand for membranes, pads, and other essential components that enable rapid, accessible testing. The growth of home-use kits and the rising reliance on decentralized testing further accelerate the consumption of these components worldwide. However, market growth faces challenges such as inconsistent performance of LFAs, especially in detecting low analyte levels, and competition from alternative diagnostic methods that provide higher accuracy for certain applications. On the opportunities side, the market benefits from expanding clinical and non-clinical uses, with increasing interest in food and beverage safety testing, which generates additional demand for high-quality assay parts. Nonetheless, industry hurdles include limited reimbursement policies that hinder broader adoption and the specialized storage and shipping requirements of LFA membranes, particularly in resource-limited settings. Despite these obstacles, the growing focus on fast, affordable diagnostics positions the lateral flow assay components market for sustained growth.
In 2024, the membranes segment held the largest share of the lateral flow assay components market by product.
The lateral flow assay components market is divided into membranes, pads, and other parts. In 2024, membranes held the largest share because they are essential as the base material where test and control lines are placed to detect analytes. Their structural and chemical features directly influence assay sensitivity, specificity, and reproducibility, making them crucial for overall test performance. In this segment, nitrocellulose remains the top material due to its excellent protein-binding ability and proven reliability in diagnostics. However, alternatives such as cellulose acetate, polyvinylidene fluoride (PVDF), charge-modified nylon, and polyethersulfone (PES) are increasingly popular for their resistance to chemicals, controlled flow rates, and compatibility with various assay chemistries. Membranes come in different pore sizes, with capillary flow time being an important factor in selection—faster flow results in quicker outcomes, while slower flow enhances sensitivity, requiring a balance based on the application. This flexibility allows membranes to be used across many diagnostic fields, including infectious disease testing, chronic disease management, food safety, and veterinary use. Ongoing advances in membrane reproducibility, surface chemistry, and uniformity continue to reinforce their market leadership, ensuring membranes remain the key component of the LFA market and the segment that generates the most revenue in 2024.
By technique, the sandwich assays held the largest share in the lateral flow assay components market in 2024.
The lateral flow assay components market is divided into sandwich assays, competitive assays, and multiplex detection assays. In 2024, sandwich assays held the largest market share, thanks to their superior sensitivity, specificity, and effectiveness in detecting larger analytes like viral antigens, bacterial pathogens, and key clinical biomarkers. This format depends on the analyte being “sandwiched” between two highly specific antibodies, creating a signal that directly correlates with analyte concentration and allows for reliable, quantitative results. The dominance of sandwich assays is supported by their widespread use in diagnostic tests such as pregnancy testing (hCG), infectious disease screening (HIV, hepatitis B, H. pylori), and cardiac marker detection (troponin, CK-MB, myoglobin). Their ability to consistently produce strong control line signals—regardless of analyte levels—further boosts diagnostic reliability, which is crucial in both clinical and home testing. As demand for point-of-care solutions rises, the need for membranes, conjugate pads, and nanoparticles optimized for sandwich assay formats continues to increase. Conversely, competitive assays remain useful for small molecules with a single antigenic site, especially in applications like drug-of-abuse testing and food safety. Meanwhile, multiplex detection assays are gaining importance because of their capacity to identify multiple targets at once. Nevertheless, the widespread clinical usefulness and proven accuracy of sandwich assays make them the main driver of component usage globally in the lateral flow assay components market.
North America dominated the global lateral flow assay components market in 2024.
The lateral flow assay components market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America, led by the U.S. and Canada, held the largest market share in 2024, supported by its advanced healthcare infrastructure, a large patient population for chronic and infectious diseases, and quick adoption of innovative diagnostic technologies. The region’s leadership is driven by a high disease burden that creates steady demand for rapid diagnostics. According to the CDC (2024), chronic conditions such as heart disease, cancer, and diabetes remain the main causes of disability and healthcare spending in the U.S., totaling nearly USD 4.5 trillion annually (17.3% of GDP). Infectious diseases also continue to drive growth, with syphilis cases among women aged 15–44 increasing by 6.8% between 2022 and 2023, and congenital syphilis cases rising by 3%—highlighting the ongoing need for accurate and accessible point-of-care testing. Additionally, academic and research institutions throughout the U.S. and Canada are playing a vital role in developing assay formats, boosting demand for high-performance membranes, pads, and nanoparticle labels. Government initiatives focused on promoting cost-effective diagnostics amid rising healthcare costs have also made LFAs attractive alternatives to centralized laboratory testing. The presence of leading suppliers—such as Danaher Corporation (Cytiva), Fortis Life Sciences, and DCN Diagnostics—further enhances the regional landscape through innovation, partnerships, and increased production capacity. Collectively, these factors cement North America’s position as the largest revenue-generating regional market for LFA components in 2024.
Key Players
Prominent players in the lateral flow assay components market are Danaher Corporation (US), Sartorius AG (Germany), Merck KGaA (Germany), Ahlstrom (Finland), Advanced Microdevices Pvt. Ltd. (India), DCN Diagnostics (US), Fortis Life Sciences, LLC. (US), Cobetter (China), Axiva Sichem Pvt. Ltd. (India), Nupore Filtration Systems(India), BALLYA (China), EQUINOX (China), Cytodiagnostics Inc (Canada), Porex (US), KENOSHA (Netherlands), AntiTeck Life Sciences Limited (China), Minipore Micro Products (India), Prahas Healthcare (India), NanoHybrids (US), ProGnosis Biotech S.A. (Greece), Lateral Dx (UK), Bangs Laboratories (US), BBI Solutions (Canada), Sona Nanotech (Canada), and Zhejiang Tailin Bioengineering Co., Ltd. (China).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Lateral Flow Assay Components Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
